[Microwave heating and neoadjuvant chemotherapy for malignant bone tumor].
Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor.
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, Margariti PA, Chiantera V, Costantini B, Gueli Alletti S, Cosentino F, Scambia G.
Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7.
Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer.
Iwamoto T, Kajiwara Y, Zhu Y, Iha S.
Chin Clin Oncol. 2020 Jun;9(3):27. doi: 10.21037/cco.2020.01.06. Epub 2020 Mar 13.
Neoadjuvant treatment for HER2-positive breast cancer.
Takada M, Toi M.
Chin Clin Oncol. 2020 Jun;9(3):32. doi: 10.21037/cco-20-123. Epub 2020 Jun 3.
Neoadjuvant chemotherapy for early-stage colon cancer.
Audisio A, Fazio R, Daprà V, Assaf I, Hendlisz A, Sclafani F.
Cancer Treat Rev. 2024 Feb;123:102676. doi: 10.1016/j.ctrv.2023.102676. Epub 2023 Dec 23.
Neoadjuvant or adjuvant chemotherapy in early breast cancer?
Montemurro F, Nuzzolese I, Ponzone R.
Expert Opin Pharmacother. 2020 Jun;21(9):1071-1082. doi: 10.1080/14656566.2020.1746273. Epub 2020 Apr 1.
Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis.
Llano-León M, Martínez-Enriquez LC, Rodríguez-Bohórquez OM, Velandia-Vargas EA, Lalinde-Ruíz N, Villota-Álava MA, Rodríguez-Rodríguez IJ, Montilla-Velásquez MDP, Parra-López CA.
PLoS One. 2023 Apr 27;18(4):e0277714. doi: 10.1371/journal.pone.0277714. eCollection 2023.
Evaluation of tumor regression by neoadjuvant chemotherapy regimens for esophageal adenocarcinoma: a systematic review and meta-analysis.
Chidambaram S, Sounderajah V, Maynard N, Owen R, Markar SR.
Dis Esophagus. 2023 Jan 28;36(2):doac058. doi: 10.1093/dote/doac058.
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis.
Zhou Y, Li A, Yu H, Wang Y, Zhang X, Qiu H, Du W, Luo L, Fu S, Zhang L, Hong S.
JAMA Netw Open. 2024 Mar 4;7(3):e241285. doi: 10.1001/jamanetworkopen.2024.1285.
Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort Study.
Nozawa K, Takatsuka D, Endo Y, Horisawa N, Ozaki Y, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H.
Anticancer Res. 2022 Jul;42(7):3735-3742. doi: 10.21873/anticanres.15863.
Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence.
Müller PC, Frey MC, Ruzza CM, Nickel F, Jost C, Gwerder C, Hackert T, Z'graggen K, Kessler U.
Pharmacology. 2021;106(3-4):143-153. doi: 10.1159/000510343. Epub 2020 Sep 23.
